Loyalty Program

Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand

Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand

By

Seven weeks after Pfizer's main Lipitor patent expired in the US, the drug is down to 32% market share and at least one name-brand analyst is casting doubt on the brand's survival strategy.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters